Fact CheckerSign in

NCT07407257Completed

SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

SBRT of Liver Tumors and Metastases and Pancreatic Tumors

Source: ClinicalTrials.gov · Last updated 18 Feb 2026

Brief summary (registry, in English)

This prospective observational study evaluates the safety and effectiveness of stereotactic body radiotherapy (SBRT) for liver tumors, liver metastases, and pancreatic tumors. The study focuses on systematic monitoring and optimization of the SBRT treatment process, including adherence to the implemented protocol, with the aim of simplifying methods while maintaining treatment safety.

Status (registry)
Completed
Study type
Interventional
Enrollment
65 (actual)
First submitted
6 Feb 2026
Start date
1 Jan 2019
Primary completion date
31 Dec 2024
Lead sponsor
Institute of Oncology Ljubljana
NCT number
NCT07407257

What you commit to

  • Study type: Interventional
  • Participants enrolled: 65
  • From 1 Jan 2019 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contraindications for SBRT according to institutional radiotherapy protocol
  • Prior radiotherapy that prevents safe SBRT delivery to the target region

Other

  • Severe uncontrolled comorbidities preventing safe SBRT treatment
  • Pregnancy
  • Inability to provide informed consent or comply with study procedures

Who the study is looking for

  • Age ≥ 18 years
  • Patients with liver tumors, liver metastases, or pancreatic tumors eligible for stereotactic body radiotherapy (SBRT)
  • Planned treatment with SBRT according to institutional protocol
  • Ability to comply with treatment and follow-up procedures
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Oncology Ljubljana
Coordinator of this site? Confirm its status
LjubljanaSloveniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.